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Acute coronary syndrome is caused by plaque disruption with superimposed thrombosis Advanced plaque is characterized by a core of extracellular 
lipid with an overlying fibrous collagen-rich cap There is little information of the dynamic nature of such plaques. Near infrared spectroscopy 
(NIRS) is able to detect lipid core containing plaque (LCP), but is unable to provide corresponding structural information which can to date only be 
achieved by performing a separate IVUS pullback. This process has the potential for malalignment, is time consuming, and exposes patients to the 
risks of two separate catheter instrumentations.
Aim: To obtain registered NIRS and IVUS data from a single catheter placement and single imaging run. 
Methods: First in human, observational study with a combined near infra-red spectroscopy and intravascular ultrasound coronary catheter (Apollo) 
in patients with stable angina pectoris. 
Results: The 3.2F Apollo catheter combined 40MHz real time IVUS (16 frames/s; pullback speed 0.5mm/s) with a standard NIRS catheter. 
Combined IVUS and NIRS data, including LCP, were successfully and safely obtained in all patients (segment length 90±12mm).
Conclusions: Simultaneous clinical assessment of coronary plaque in vivo using IVUS and inherently co-registered NIRS is able to provide 
structural information comparable to standrad IVUS and additional important information on plaque composition, which may increase the ability to 
correctly identify plaque at risk of rupture in th future.
